Manu De Rycker

2.6k total citations · 1 hit paper
32 papers, 1.4k citations indexed

About

Manu De Rycker is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Manu De Rycker has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 18 papers in Public Health, Environmental and Occupational Health and 13 papers in Molecular Biology. Recurrent topics in Manu De Rycker's work include Trypanosoma species research and implications (24 papers), Research on Leishmaniasis Studies (18 papers) and Synthesis and Biological Evaluation (8 papers). Manu De Rycker is often cited by papers focused on Trypanosoma species research and implications (24 papers), Research on Leishmaniasis Studies (18 papers) and Synthesis and Biological Evaluation (8 papers). Manu De Rycker collaborates with scholars based in United Kingdom, United States and Spain. Manu De Rycker's co-authors include Ian H. Gilbert, David W. Gray, Susan Wyllie, Carolyn M. Price, Kevin D. Read, Alan H. Fairlamb, David Horn, Paul G. Wyatt, Suzanne Duce and Beatriz Baragaña and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Manu De Rycker

30 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

2017 306 citations Mark C. Field, David Horn et al. Nature Reviews Microbiology profile →

Peers

Countries citing papers authored by Manu De Rycker

Since Specialization

Citations

This map shows the geographic impact of Manu De Rycker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manu De Rycker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manu De Rycker more than expected).

Fields of papers citing papers by Manu De Rycker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manu De Rycker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manu De Rycker. The network helps show where Manu De Rycker may publish in the future.

Co-authorship network of co-authors of Manu De Rycker

This figure shows the co-authorship network connecting the top 25 collaborators of Manu De Rycker. A scholar is included among the top collaborators of Manu De Rycker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manu De Rycker. Manu De Rycker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis	Communications Biology	Bilal Zulfiqar, Fábio Antônio Colombo et al.	0
2	Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity	PLoS neglected tropical diseases	De Lin, Sandra M. O’Neill et al.	1
3	Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitors	Journal of Biological Chemistry	Leah S. Torrie, Paul Rowland et al.	1
4	Validation of Trypanosoma cruzi inactivation techniques for laboratory use	PLoS ONE	Lorna MacLean, Mark R. Ariyanayagam et al.	0
5	Author Correction: Anti-trypanosomatid drug discovery: progress and challenges	Nature Reviews Microbiology	Manu De Rycker, Susan Wyllie et al.	5
6	Anti-trypanosomatid drug discovery: progress and challenges	Nature Reviews Microbiology	Manu De Rycker, Susan Wyllie et al.	99
7	Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay	PLoS neglected tropical diseases	Nina Svensen, Susan Wyllie et al.	6
8	Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinase	PLoS ONE	Leah S. Torrie, Fabio Zuccotto et al.	4
9	Challenges and recent progress in drug discovery for tropical diseases	Nature	Manu De Rycker, Beatriz Baragaña et al.	153
10	Author Correction: Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need	Nature Reviews Microbiology	Mark C. Field, David Horn et al.	3
11	2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas’ disease	Bioorganic & Medicinal Chemistry Letters	Michael G. Thomas, Manu De Rycker et al.	4
12	Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery	PLoS neglected tropical diseases	Lorna MacLean, John Thomas et al.	81
13	Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need breakdown →	Nature Reviews Microbiology	Mark C. Field, David Horn et al.	306
14	Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade	PLoS neglected tropical diseases	Manu De Rycker, John Thomas et al.	52
15	Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity	PLoS neglected tropical diseases	Manu De Rycker, Sujatha Manthri et al.	30
16	Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay	Antimicrobial Agents and Chemotherapy	Manu De Rycker, Irene Hallyburton et al.	108
17	A Static-Cidal Assay for Trypanosoma brucei to Aid Hit Prioritisation for Progression into Drug Discovery Programmes	PLoS neglected tropical diseases	Manu De Rycker, Sandra M. O’Neill et al.	30
18	Regulatory Domain Selectivity in the Cell-Type Specific PKN-Dependence of Cell Migration	PLoS ONE	Sylvie Lachmann, Manu De Rycker et al.	64
19	A High‐Content, Cell‐Based Screen Identifies Micropolyin, A New Inhibitor of Microtubule Dynamics	Chemical Biology & Drug Design	Manu De Rycker, Laurent Rigoreau et al.	13
20	Pressor and renal effects of cross-linked hemoglobin in anesthetized cirrhotic rats	Journal of Hepatology	M. Clara Ortíz, Lourdes A. Fortepiani et al.	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact